Kinslow C, Rae A, Taparra K, Kumar P, Siegelin M, Grinband J
Clin Cancer Res. 2023; 29(21):4399-4407.
PMID: 37611077
PMC: 10872921.
DOI: 10.1158/1078-0432.CCR-23-1295.
Montecillo-Aguado M, Tirado-Rodriguez B, Tong Z, Vega O, Morales-Martinez M, Abkenari S
Brain Sci. 2020; 10(6).
PMID: 32560280
PMC: 7349634.
DOI: 10.3390/brainsci10060381.
Lee M, Han K, Ahn S, Bae S, Choi Y, Hong J
J Neurooncol. 2019; 142(1):129-138.
PMID: 30604396
DOI: 10.1007/s11060-018-03072-0.
Valiyaveettil D, Malik M, Joseph D, Ahmed S, Kothwal S
South Asian J Cancer. 2018; 7(1):1-4.
PMID: 29600221
PMC: 5865085.
DOI: 10.4103/sajc.sajc_55_17.
Dube-Delarosbil C, St-Pierre Y
Cell Mol Life Sci. 2017; 75(7):1215-1226.
PMID: 29119229
PMC: 11105754.
DOI: 10.1007/s00018-017-2708-5.
Usefulness of PET Imaging to Guide Treatment Options in Gliomas.
Suchorska B, Albert N, Tonn J
Curr Treat Options Neurol. 2016; 18(1):4.
PMID: 26815310
DOI: 10.1007/s11940-015-0384-z.
Identifying the association between contrast enhancement pattern, surgical resection, and prognosis in anaplastic glioma patients.
Wang Y, Wang K, Wang J, Li S, Ma J, Dai J
Neuroradiology. 2016; 58(4):367-74.
PMID: 26795126
DOI: 10.1007/s00234-016-1640-y.
Procarbazine, lomustine and vincristine or temozolomide: which is the better regimen?.
Lassman A
CNS Oncol. 2015; 4(5):341-6.
PMID: 26544062
PMC: 6082332.
DOI: 10.2217/cns.15.36.
Patterns of Tumor Contrast Enhancement Predict the Prognosis of Anaplastic Gliomas with IDH1 Mutation.
Wang Y, Wang K, Li S, Wang J, Ma J, Jiang T
AJNR Am J Neuroradiol. 2015; 36(11):2023-9.
PMID: 26316565
PMC: 7964858.
DOI: 10.3174/ajnr.A4407.
Regulation of expression of O6-methylguanine-DNA methyltransferase and the treatment of glioblastoma (Review).
Cabrini G, Fabbri E, Lo Nigro C, Dechecchi M, Gambari R
Int J Oncol. 2015; 47(2):417-28.
PMID: 26035292
PMC: 4501657.
DOI: 10.3892/ijo.2015.3026.
Radiotherapy and temozolomide for anaplastic astrocytic gliomas.
Nayak L, Panageas K, Reiner A, Huse J, Pentsova E, Braunthal S
J Neurooncol. 2015; 123(1):129-34.
PMID: 25920709
PMC: 4606458.
DOI: 10.1007/s11060-015-1771-8.
Identifying the association of contrast enhancement with vascular endothelia growth factor expression in anaplastic gliomas: a volumetric magnetic resonance imaging analysis.
Wang Y, Wang K, Li H, Wang J, Wang L, Dai J
PLoS One. 2015; 10(3):e0121380.
PMID: 25823012
PMC: 4379034.
DOI: 10.1371/journal.pone.0121380.
The future of high-grade glioma: Where we are and where are we going.
Le Rhun E, Taillibert S, Chamberlain M
Surg Neurol Int. 2015; 6(Suppl 1):S9-S44.
PMID: 25722939
PMC: 4338495.
DOI: 10.4103/2152-7806.151331.
MicroRNA expression patterns in the malignant progression of gliomas and a 5-microRNA signature for prognosis.
Yan W, Li R, Liu Y, Yang P, Wang Z, Zhang C
Oncotarget. 2014; 5(24):12908-15.
PMID: 25415048
PMC: 4350338.
DOI: 10.18632/oncotarget.2679.
Pattern of care of anaplastic oligodendroglioma and oligoastrocytoma in a Korean population: the Korean Radiation Oncology Group study 13-12.
Yu T, Kang H, Lim D, Kim I, Chung W, Suh C
J Neurooncol. 2014; 121(3):531-9.
PMID: 25391968
DOI: 10.1007/s11060-014-1660-6.
Case presentation - A five-year survival of the patient with glioblastoma brain tumor.
Urbanczyk H, Straczynska-Niemiec A, Glowacki G, Lange D, Miszczyk L
Rep Pract Oncol Radiother. 2014; 19(5):347-51.
PMID: 25184061
PMC: 4150096.
DOI: 10.1016/j.rpor.2014.04.002.
Adult brain cancer in the U.S. black population: a Surveillance, Epidemiology, and End Results (SEER) analysis of incidence, survival, and trends.
Gabriel A, Batey J, Capogreco J, Kimball D, Walters A, Tubbs R
Med Sci Monit. 2014; 20:1510-7.
PMID: 25151984
PMC: 4156338.
DOI: 10.12659/MSM.890762.
MRI grading versus histology: predicting survival of World Health Organization grade II-IV astrocytomas.
Lasocki A, Tsui A, Tacey M, Drummond K, Field K, Gaillard F
AJNR Am J Neuroradiol. 2014; 36(1):77-83.
PMID: 25104288
PMC: 7965922.
DOI: 10.3174/ajnr.A4077.
The impact of concurrent temozolomide with adjuvant radiation and IDH mutation status among patients with anaplastic astrocytoma.
Kizilbash S, Giannini C, Voss J, Decker P, Jenkins R, Hardie J
J Neurooncol. 2014; 120(1):85-93.
PMID: 24993250
PMC: 4229369.
DOI: 10.1007/s11060-014-1520-4.
Malignant gliomas: current perspectives in diagnosis, treatment, and early response assessment using advanced quantitative imaging methods.
Ahmed R, Oborski M, Hwang M, Lieberman F, Mountz J
Cancer Manag Res. 2014; 6:149-70.
PMID: 24711712
PMC: 3969256.
DOI: 10.2147/CMAR.S54726.
